These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 19833178)
1. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Teskac K; Kristl J Int J Pharm; 2010 May; 390(1):61-9. PubMed ID: 19833178 [TBL] [Abstract][Full Text] [Related]
2. [Study on preparation and characterization of resveratrol solid lipid nanoparticles and its anticancer effects in vitro]. Zhang QH; Xiong QP; Shi YY; Zhang DY Zhong Yao Cai; 2010 Dec; 33(12):1929-32. PubMed ID: 21548373 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933 [TBL] [Abstract][Full Text] [Related]
4. Preparation and cytotoxicity of 2-methoxyestradiol-loaded solid lipid nanoparticles. Guo X; Xing Y; Mei Q; Zhang H; Zhang Z; Cui F Anticancer Drugs; 2012 Feb; 23(2):185-90. PubMed ID: 22027535 [TBL] [Abstract][Full Text] [Related]
5. In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Jose S; Anju SS; Cinu TA; Aleykutty NA; Thomas S; Souto EB Int J Pharm; 2014 Oct; 474(1-2):6-13. PubMed ID: 25102112 [TBL] [Abstract][Full Text] [Related]
6. Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: Antibiotic resistance tests and HaCat and NIH/3T3 cell viability studies. Severino P; Chaud MV; Shimojo A; Antonini D; Lancelloti M; Santana MH; Souto EB Colloids Surf B Biointerfaces; 2015 May; 129():191-7. PubMed ID: 25863712 [TBL] [Abstract][Full Text] [Related]
7. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282 [TBL] [Abstract][Full Text] [Related]
8. Improvements of cellular stress response on resveratrol in liposomes. Kristl J; Teskac K; Caddeo C; Abramović Z; Sentjurc M Eur J Pharm Biopharm; 2009 Oct; 73(2):253-9. PubMed ID: 19527785 [TBL] [Abstract][Full Text] [Related]
9. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery. Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156 [TBL] [Abstract][Full Text] [Related]
10. Chitosan-solid lipid nanoparticles as carriers for topical delivery of tretinoin. Ridolfi DM; Marcato PD; Justo GZ; Cordi L; Machado D; Durán N Colloids Surf B Biointerfaces; 2012 May; 93():36-40. PubMed ID: 22244299 [TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake. Luo Y; Teng Z; Li Y; Wang Q Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662 [TBL] [Abstract][Full Text] [Related]
12. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method]. Yang Y; Feng JF; Zhang H; Luo JY Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):650-3. PubMed ID: 16830822 [TBL] [Abstract][Full Text] [Related]
13. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies. Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546 [TBL] [Abstract][Full Text] [Related]
14. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667 [TBL] [Abstract][Full Text] [Related]
15. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles. Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992 [TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside. Zhang X; Lü S; Han J; Sun S; Wang L; Li Y Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077 [TBL] [Abstract][Full Text] [Related]
17. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions. Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414 [TBL] [Abstract][Full Text] [Related]
18. Development of DH-I-180-3 loaded lipid nanoparticle for photodynamic therapy. Park JH; Ban SJ; Ahmed T; Choi HS; Yoon HE; Yoon JH; Choi HK Int J Pharm; 2015 Aug; 491(1-2):393-401. PubMed ID: 26149935 [TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration. Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845 [TBL] [Abstract][Full Text] [Related]
20. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Garg A; Singh S Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]